Xenon Pharmaceuticals XENE Return on equity

Return on equity at other companies

Eli LillyLLY

102.4%+15.7pp

Johnson & JohnsonJNJ

25.7%-4.5pp

Jazz PharmaceuticalsJAZZ

-9.1%-21.2pp

Axsome TherapeuticsAXSM

-349.4%+109pp

Stoke Therapeutics, Inc.STOK

-45.6%-66.1pp

Praxis Precision Medicines, Inc.PRAX

-38.9%-10.3pp

FAQ

What is Xenon Pharmaceuticals's return on equity?

Xenon Pharmaceuticals (XENE) reported return on equity of -43.6% in Q2 2026.

How has Xenon Pharmaceuticals's return on equity changed year-over-year?

Xenon Pharmaceuticals's return on equity decreased by 15.8% year-over-year, from -37.6% to -43.6%.

What is the long-term trend for Xenon Pharmaceuticals's return on equity?

Over 5 years (2020 to 2025), Xenon Pharmaceuticals's return on equity has grown at a 18.8% compound annual growth rate (CAGR), from -21.9% to -51.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.